WallStreetZen

NYSE: ABT
Abbott Laboratories Stock Forecast, Predictions & Price Target

Analyst price target for ABT

Based on 10 analysts offering 12 month price targets for Abbott Laboratories.
Min Forecast
$101.00-16.46%
Avg Forecast
$123.00+1.74%
Max Forecast
$140.00+15.8%

Should I buy or sell ABT stock?

Strong Buy
Strong Buy
5 analysts 50%
Buy
4 analysts 40%
Hold
1 analysts 10%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ABT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Anonymous
Morgan Stanley
Strong BuyMaintains$136.00+12.49%2021-01-28
Marie Thibault
BTIG
Strong BuyUpgrades$140.00+15.80%2021-01-28
Matthew Taylor
UBS
Strong BuyMaintains$109.00-9.84%2020-04-17
Joanne Wuensch
Citigroup
Strong BuyMaintains$109.00-9.84%2020-04-17
Larry Biegelsen
Wells Fargo
Strong BuyMaintains$107.00-11.50%2020-04-17
Jayson Bedford
Raymond James
BuyMaintains$130.00+7.53%2021-03-11
Joshua Jennings
Cowen & Co.
BuyMaintains$140.00+15.80%2021-01-28
Matt Miksic
Credit Suisse
BuyMaintains$130.00+7.53%2021-01-28
Kevin Huang
CFRA
BuyMaintains$101.00-16.46%2020-04-16
Danielle Antalffy
SVB Leerink
HoldMaintains$128.00+5.87%2021-01-28

1 of 1

Forecast return on equity

Is ABT forecast to generate an efficient return?
Company
34.21%
Industry
-113.33%
Market
32,369.88%
ABT's Return on Equity is forecast to be high in 3 years (34.21%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ABT forecast to generate an efficient return on assets?
Company
15.56%
Industry
14.17%
Market
11,660.33%
ABT is forecast to generate higher Return on Assets (15.56%) than the US Medical Devices industry average (14.17%)
Forecast

ABT earnings per share forecast

What is ABT's earnings per share in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$5.07+101.11%
Avg 2 year Forecast
$5.33+111.42%
Avg 3 year Forecast
$5.95+136.11%
ABT's earnings are forecast to grow at an exceptional rate of 32.12% per year
Forecast

ABT revenue forecast

What is ABT's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$42.4B+22.59%
Avg 2 year Forecast
$42.3B+22.31%
Avg 3 year Forecast
$44.6B+28.88%
ABT's revenue is forecast to grow at a rate of 8.21% per year, which is not exceptional
Forecast

ABT earnings growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
32.12%
Industry
26.34%
Market
23.13%
ABT's earnings are forecast to grow faster (32.12% per year) than the US Medical Devices industry average (26.34%)
Forecast
ABT's earnings are forecast to grow faster (32.12% per year) than the US market average (23.13%)
Forecast
ABT's earnings are forecast to grow faster (32.12% per year) than the risk-free savings rate (1.7%)
Forecast

ABT revenue growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
8.21%
Industry
11.12%
Market
15.05%
ABT's revenues are forecast to grow slower (8.21% per year) than the US Medical Devices industry average (11.12%)
Forecast
ABT's revenues are forecast to grow slower (8.21% per year) than the US market average (15.05%)
Forecast

Abbott Laboratories Stock Forecast FAQ

Is Abbott Laboratories Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NYSE: ABT) stock is to Strong Buy ABT stock.

Out of 10 analysts, 5 (50%) are recommending ABT as a Strong Buy, 4 (40%) are recommending ABT as a Buy, 1 (10%) are recommending ABT as a Hold, 0 (0%) are recommending ABT as a Sell, and 0 (0%) are recommending ABT as a Strong Sell.

What is ABT's earnings growth forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's forecast annual earnings growth rate of 32.12% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 26.34%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 23.13%.

Abbott Laboratories's earnings in 2021 is $4,495,000,000.On average, 10 Wall Street analysts forecast ABT's earnings for 2021 to be $8,982,328,493, with the lowest ABT earnings forecast at $8,861,807,905, and the highest ABT earnings forecast at $9,287,174,684. On average, 9 Wall Street analysts forecast ABT's earnings for 2022 to be $9,442,788,031, with the lowest ABT earnings forecast at $7,443,918,640, and the highest ABT earnings forecast at $9,978,395,701.

In 2023, ABT is forecast to generate $10,545,551,407 in earnings, with the lowest earnings forecast at $10,350,591,633 and the highest earnings forecast at $10,651,893,102.

What is ABT's revenue growth forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's forecast annual revenue growth rate of 8.21% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 11.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.05%.

Abbott Laboratories's revenue in 2021 is $34,608,000,000.On average, 7 Wall Street analysts forecast ABT's revenue for 2021 to be $75,194,834,534,421, with the lowest ABT revenue forecast at $74,483,495,441,525, and the highest ABT revenue forecast at $77,383,078,988,041. On average, 7 Wall Street analysts forecast ABT's revenue for 2022 to be $75,021,953,068,725, with the lowest ABT revenue forecast at $72,769,621,792,698, and the highest ABT revenue forecast at $79,169,619,461,689.

In 2023, ABT is forecast to generate $79,054,905,130,720 in revenue, with the lowest revenue forecast at $76,606,483,314,094 and the highest revenue forecast at $83,121,985,787,319.

What is ABT's forecast return on assets (ROA) for 2021-2024?

(NYSE: ABT) forecast ROA is 15.56%, which is higher than the forecast US Medical Devices industry average of 14.17%.

What is ABT's Price Target?

According to 10 Wall Street analysts that have issued a 1 year ABT price target, the average ABT price target is $123.00, with the highest ABT stock price forecast at $140.00 and the lowest ABT stock price forecast at $101.00.

On average, Wall Street analysts predict that Abbott Laboratories's share price could stay at $123.00 by Mar 11, 2022. The average Abbott Laboratories stock price prediction forecasts a potential downside of N/A from the current ABT share price of $120.90.

What is ABT's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's current Earnings Per Share (EPS) is $2.52. On average, analysts forecast that ABT's EPS will be $5.07 for 2021, with the lowest EPS forecast at $5.00, and the highest EPS forecast at $5.24. On average, analysts forecast that ABT's EPS will be $5.33 for 2022, with the lowest EPS forecast at $4.20, and the highest EPS forecast at $5.63. In 2023, ABT's EPS is forecast to hit $5.95 (min: $5.84, max: $6.01).

What is ABT's forecast return on equity (ROE) for 2021-2024?

(NYSE: ABT) forecast ROE is 34.21%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.